Optimization & Scale-up of Bioprocesses : Influenza Vaccine Production in 
Microcarrier Systems

Genzel, Y.; Best, C.; Behrendt, I.; König, S.; Sann, H.; Bock, A.; Reichl, U.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Poster

Optimization & Scale-up of Bioprocesses : Influenza Vaccine Production in Microcarrier Systems

MPS-Authors

/persons/resource/persons86303

Genzel, Y.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86251

Behrendt, I.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86371

König, S.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86461

Sann, H.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86258

Bock, A.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

/persons/resource/persons86448

Reichl, U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Genzel, Y., Best, C., Behrendt, I., König, S., Sann, H., Bock, A., et al. (2003). Optimization & Scale-up of Bioprocesses: Influenza Vaccine Production in Microcarrier Systems. Poster presented at Bioengineering Course (BEC), Supetar, Croatia.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0013-9F1C-E

Abstract

The background of a new project Monitoring and Control of High Density Cell Culture Systems is presented. The aim is the development of integrated concepts to design and optimize vaccine production processes. Besides the amelioration of viral yields and reproducibility of these processes our focus is the establishment of downstream processing methods to improve efficacy, purity and safety of vaccines. With a process of equine influenza virus production as an example we investigate: (a) Cultivation and scale-up of animal cells (MDCK) using microcarrier systems (b) Replication of influenza viruses (equine influenza Newmarket 1/93 H3N8) (c) Downstream processing to subunit or split vaccines. Within this concept the aim is to characterize options, advantages and limitations of high density animal cell culture technologies. Based on mathematical models describing cell growth and virus replication in bioreactors, different control strategies will be established and the results will be compared with existing cultivation techniques.